Barbara J. Gitlitz

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip, Nasser K. Altorki, Caicun Zhou et al. · The Lancet · 2021 · 1.4K citations

Oncology, Adjuvant Chemotherapy, Pathology +6

Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

Amnon Zisman, Allan J. Pantuck, Fredrick Dorey et al. · Journal of Clinical Oncology · 2001 · 727 citations

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui et al. · Journal of Clinical Oncology · 2018 · 455 citations · Full text

Metastatic Npc, Oncology, Antitumor Activity +15

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer

Lecia V. Sequist, Benjamin Besse, Thomas J. Lynch et al. · Journal of Clinical Oncology · 2010 · 420 citations · Full text

Renal Cell Carcinoma With Retroperitoneal Lymph Nodes: Role of Lymph Node Dissection

Allan J. Pantuck, Amnon Zisman, Fredrick Dorey et al. · The Journal of Urology · 2003 · 304 citations